Leveraging proprietary technologies to address significant unmet medical needs.
Ironshore Pharmaceuticals & Development, Inc. has developed a novel oral, once-daily, drug delivery technology. DELEXIS has delayed-release properties that limit the release of the medication overnight and extended-release properties that control the release of the medication throughout the following day.
Learn more about the DELEXIS DDP's micro-bead technology, and how it works to delay the absorption of drug doses.
Watch the DELEXIS micro-beads in action and see the controlled release of drugs as the beads move through a patient from ingestion to absorption.
Learn how the DELEXIS DDP can be used to optimize the delivery of existing medicines.